Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hematology
Volume 2014 (2014), Article ID 364693, 4 pages
http://dx.doi.org/10.1155/2014/364693
Case Report

Successful Treatment of Mild Pediatric Kasabach-Merritt Phenomenon with Propranolol Monotherapy

Department of Pediatrics, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand

Received 19 March 2014; Accepted 7 May 2014; Published 22 May 2014

Academic Editor: Panagiotis Tsirigotis

Copyright © 2014 Worawut Choeyprasert et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Kasabach and K. Merritt, “Capillary hamangioma with extensive purpura,” The American Journal of Diseases of Children, vol. 59, no. 5, pp. 1063–1070, 1940. View at Publisher · View at Google Scholar
  2. O. Enjolras, M. Wassef, E. Mazoyer et al., “Infants with Kasabach-Merritt syndrome do not have “true” hemangiomas,” The Journal of Pediatrics, vol. 130, no. 4, pp. 631–640, 1997. View at Publisher · View at Google Scholar
  3. D. M. Szlachetka, “Kasabach-Merritt syndrome: a case review,” Neonatal Network, vol. 17, no. 1, pp. 7–15, 1998. View at Google Scholar · View at Scopus
  4. M. Kelly, “Kasabach-Merritt phenomenon,” Pediatric Clinics of North America, vol. 57, no. 5, pp. 1085–1089, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Hogeling, S. Adams, and O. Wargon, “A randomized controlled trial of propranolol for infantile hemangiomas,” Pediatrics, vol. 128, no. 2, pp. e259–e266, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. B. A. Drolet, P. C. Frommelt, S. L. Chamlin et al., “Initiation and use of propranolol for infantile hemangioma: report of a consensus conference,” Pediatrics, vol. 131, no. 1, pp. 128–140, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. V. Sans, E. D. de la Roque, J. Berge et al., “Propranolol for severe infantile hemangiomas: follow-up report,” Pediatrics, vol. 124, no. 3, pp. e423–e431, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. D. J. J. Hermans, I. M. van Beynum, R. J. van der Vijver, L. Jan Schultze Kool, I. de Blaauw, and C. J. M. van der Vleuten, “Kaposiform hemangioendothelioma with Kasabach-Merritt syndrome: a new indication for propranolol treatment,” Journal of Pediatric Hematology/Oncology, vol. 33, no. 4, pp. e171–e173, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. E. Chiu, B. A. Drolet, F. Blei et al., “Variable response to propranolol treatment of kaposiform hemangioendothelioma, tufted angioma, and Kasabach-Merritt phenomenon,” Pediatric Blood and Cancer, vol. 59, no. 5, pp. 934–938, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. B. A. Drolet, C. C. Trenor III, L. R. Brandão et al., “Consensus-derived practice standards plan for complicated Kaposiform hemangioendothelioma,” The Journal of Pediatrics, vol. 163, no. 1, pp. 285–291, 2013. View at Publisher · View at Google Scholar
  11. C. Haisley-Royster, O. Enjolras, I. J. Frieden et al., “Kasabach-Merritt phenomenon: a retrospective study of treatment with vincristine,” Journal of Pediatric Hematology/Oncology, vol. 24, no. 6, pp. 459–462, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. F. Fahrtash, E. McCahon, and S. Arbuckle, “Successful treatment of kaposiform hemangioendothelioma and tufted angioma with vincristine,” Journal of Pediatric Hematology/Oncology, vol. 32, no. 6, pp. 506–510, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. G. W. Hall, “Kasabach-Merritt syndrome: pathogenesis and management,” British Journal of Haematology, vol. 112, no. 4, pp. 851–862, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. N. Yasui, K. Koh, M. Kato et al., “Kasabach-merritt phenomenon: a report of 11 cases from a single institution,” Journal of Pediatric Hematology/Oncology, vol. 35, no. 7, pp. 554–558, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Léauté-Labrèze, E. D. de la Roque, T. Hubiche, F. Boralevi, J.-B. Thambo, and A. Taïeb, “Propranolol for severe hemangiomas of infancy,” New England Journal of Medicine, vol. 358, no. 24, pp. 2649–2651, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. F. Blei, N. Karp, N. Rofsky, R. Rosen, and M. A. Greco, “Successful multimodal therapy for kaposiform hemagioendothelioma complicated by Kasabach-Merritt,” Pediatric Hematology and Oncology, vol. 15, no. 4, pp. 295–305, 1998. View at Google Scholar · View at Scopus
  17. P. Arunachalam, V. R. Kumar, and D. Swathi, “Kasabach-Merritt syndrome with large cutaneous vascular tumors,” Journal of Indian Association of Pediatric Surgeons, vol. 17, no. 1, pp. 33–36, 2012. View at Publisher · View at Google Scholar